Aug 1984 Ph.D., Department of Pathology, State University of New York at Stony Brook (Thesis: The development of pulmonary host defense in the neonatal sheep)

Jun 1978 B.S., Department of Biological Sciences, State University of New York at Stony Brook

Jun 1976 A.A.S., Department of Biotechnology, State University of New York at Farmingdale

Aug 1998-present Principal Consultant, The INDA Group, Chicago, IL

Oct 1997-Jul 1998 Director, Project Management/Clinical Development Services, Affiliated Research Centers, Inc., Gurnee, IL

May 1995-Oct 1997 Ass't. Director, Clinical Development, TAP Holdings Inc., Deerfield, IL

Dec 1993-May 1995 Sr. Clinical Project Manager, TAP Pharmaceuticals Inc., Deerfield, IL

Nov 1990-Dec 1993 Clinical Project Manager, TAP Pharmaceuticals Inc., Deerfield, IL

Apr 1989-Nov 1990 Sr. Clinical Research Associate, TAP Pharmaceuticals Inc., Deerfield, IL

Aug 1987-Apr 1989 Biologist II, Hepatitis and AIDS Research, Abbott Laboratories, Abbott Park, IL

Sep 1985-Aug 1987 Postdoctoral Scientist, Department of Experimental Pathology, SmithKline & French Laboratories, King of Prussia, PA

Aug 1984-Aug 1985 Postdoctoral Fellow, Division of Allergy, Rheumatology & Clinical Immunology, Department of Medicine, State University of New York at Stony Brook

1989 Presidential Award, Abbott Laboratories

Jun 1978 Departmental Honors, Department of Biological Sciences, State University of New York at Stony Brook

1984-1987 Research Collaborator, Medical Department, Brookhaven National Laboratory, Upton, NY

American Society of Clinical Oncology
National Cancer Institute, Associates Program

Responsibilities: investigator, contract research organization, and consultant recruitment and collaboration; protocol design/development; study implementation; monitoring; study report preparation; preparation of regulatory submissions (INDs, annual reports, IDBs); scientific presentations; development of compassionate use program; supervisory (Clinical Research Managers, Clinical Research Associates and Assistants, and contract monitors); interactions with statisticians, data managers, regulatory managers, drug formulation and preclinical scientists

Disease Indications: oncology (solid tumors); psychiatry (generalized anxiety disorder, panic disorder); neurology (stroke, Alzheimer's disease, Huntington's disease)

Developmental Phases: Phases 1-3

Weiss RA, Chanana AD and Joel DD: Localized Pulmonary Neutrophil Influx Induced By Lung Lavage In Sheep. Lung 161:369-374, 1983.

Weiss RA, Chanana AD and Joel DD: The Status Of Pulmonary Host Defense In the Neonatal Sheep: Cellular and Humoral Aspects. Annals of the New York Academy of Science 459:40-55, 1985.

Weiss RA, Chanana AD and Joel DD: Postnatal Maturation of Pulmonary Antimicrobial Defense Mechanisms in Convention and Germfree Lambs. Pediatr. Res. 20(6):496-504, 1986.

Weiss RA, Silverberg M and Kaplan AP: The Effect of C1 Inhibitor on Hageman Factor Autoactivation. Blood 68(1):239-241, 1986.

Fleit HG, Weiss RA, Chanana AD and Joel DD: Fc Receptor Function of Sheep Alveolar Macrophages. J. Leukocyte Biol. 40:419-431, 1986.

Weiss RA, Meunier PC, Kelley A, Klinkner A, Badger AM and PJ Bugelski: Activation of Rat Pulmonary Lavage Cells by Intratracheal Administration of Polyinosinic-polycytidilic Acid. J Biologic Response Modifiers 9:411-419, 1990.

Milkowski DM and RA Weiss: TNP-470, Preclinical and Clinical Development. Chapter In D'Amore P and E Voest (Ed.): Tumor Angiogenesis and Microcirculation, New York: Marcel Dekker, (in press).

Milkowski DM and RA Weiss: TNP-470. Chapter In Teicher, B (Ed.): Antiangiogenic Agents in Cancer Therapy, Cancer Drug Discovery and Development, Totowa, NJ: Humana Press Inc., p. 385-398, 1998.